SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-013703
Filing Date
2019-04-29
Accepted
2019-04-29 16:05:21
Documents
2
Period of Report
2019-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20190429.htm 8-K 35781
2 EX-99.1 crsp-ex991_10.htm EX-99.1 127883
  Complete submission text file 0001564590-19-013703.txt   164756
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 19775873
SIC: 2836 Biological Products, (No Diagnostic Substances)